Abstract:Inspired by the lysosomal swelling caused by excessive accumulation of undegraded substances, a lysosomal‐targeting aggregated nanoparticle (LTANP) is synthesized for cancer treatment. By rationally engineering surface properties and interparticle interactions, LTANP enables targeted aggregation in lysosomes of cancer cells, leading to unrelievable lysosomal swelling, and ultimately selectively inducing lysosomal membrane permeabilization and immunogenic cell death of cancer cells. Nanotechnology has proven its enormous application value in clinical practice. However, current research on nanomedicines mainly focuses on developing nanoparticles as delivery carriers to maximize the bioavailability of therapeutic agents, with little attention on exploring their potential to directly regulate physiological processes. In this study, inspired by the lysosomal swelling caused by excessive accumulation of undegraded substances, this work presents a lysosomal‐targeting aggregated nanoparticle (LTANP) for cancer treatment. By rationally engineering surface composition, properties, and interparticle interactions, LTANP achieves efficient tumor accumulation and selective targeted aggregation in lysosomes of cancer cells, leading to unrelievable lysosomal swelling, and ultimately inducing lysosomal membrane permeabilization (LMP) of cancer cells. Further analysis shows that nanoparticle aggregation‐mediated LMP can effectively trigger immunogenic cell death (ICD) by impairing autophagy‐lysosome pathway, evoking robust antitumor immune responses and reversing tumor immunogenicity from "cold" to "hot" in a melanoma model. Additionally, LTANP can combine with clinically approved programmed death ligand‐1 (PD‐L1) antibodies to further unleash T cell‐mediated antitumor immunity, significantly enhancing antitumor performance, inhibiting tumor recurrence and metastasis. This work demonstrates the potential of rationally engineered nanostructures in directly combating cancer and provides novel insights for the development of advanced nanoparticle‐based cancer treatment.

A Nanotheranostic System Combining Lysosomal Cell Death and Nuclear Apoptosis Functions for Synergistic Cancer Therapy and Addressing Drug Resistance

Mitochondrial-Targeting Lonidamine-Doxorubicin Nanoparticles for Synergistic Chemotherapy to Conquer Drug Resistance.

Unlocking lysosomal acidity to activate membranolytic module for accurately cancer theranostics

Mitochondrial-targeting Nanoprodrugs to Mutually Reinforce Metabolic Inhibition and Autophagy for Combating Resistant Cancer.

Multi-responsive nanotheranostics with enhanced tumor penetration and oxygen self-producing capacities for multimodal synergistic cancer therapy

Molecular and Supramolecular Engineering on Lipopeptide-Based Hole-Punching Nanotoxins to Trigger Multimodal Death of Drug-Resistant Tumors: Apoptosis, Necrosis and Autophagy

Nanomaterials Respond to Lysosomal Function for Tumor Treatment

Nanodrugs Detonate Lysosome Bombs

Mitochondria-targeting polydopamine-coated nanodrugs for effective photothermal- and chemo-synergistic therapies against lung cancer

A Programmed Nanoparticle with Self-Adapting for Accurate Cancer Cell Eradication and Therapeutic Self-Reporting.

Stimuli responsive nanoplatform with mitochondria-specific multiple model therapeutics for effective tumor treatment

Mitochondria‐ and Lysosomes‐Targeted Synergistic Chemo‐Photodynamic Therapy Associated with Self‐Monitoring by Dual Light‐Up Fluorescence

Lysosome Targeted Nanoparticle Aggregation Reverses Immunosuppressive Tumor Microenvironment for Cancer Immunotherapy

Engineering Nanoplatform for Combined Cancer Therapeutics via Complementary Autophagy Inhibition

Self-assembled Ternary Hybrid Nanodrugs for Overcoming Tumor Resistance and Metastasis

NIR-triggered and Thermoresponsive Core-shell nanoparticles for synergistic anticancer therapy

Metabolism-Regulating Nanozyme System for Advanced Nanocatalytic Cancer Therapy

Mitochondria Apoptosis Pathway Synergistically Activated by Hierarchical Targeted Nanoparticles Co-Delivering Sirna and Lonidamine.

Stepwise Dual Targeting and Dual Responsive Polymer Micelles for Mitochondrion Therapy.

Silk Fibroin-Coated Nanoagents for Acidic Lysosome Targeting by a Functional Preservation Strategy in Cancer Chemotherapy.

A Sequentially Triggered Nanosystem for Precise Drug Delivery and Simultaneous Inhibition of Cancer Growth, Migration, and Invasion